Patent details
EP2404614 Title: Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization
Basic Information
- Publication number:
- EP2404614
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP111843082
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization
- French Title of Invention:
- VACCIN UNIVERSEL A BASE DE CELLULES TUMORALES POUR UTILISATION THERAPEUTIQUE OU PROPHYLACTIQUE DU CANCER
- German Title of Invention:
- UNIVERSELLER TUMORZELLENIMPFSTOFF FÜR ANTIKREBSTHERAPIE- UND PROPHYLAXEVERWENDUNG
- SPC Number:
Dates
- Filing date:
- 20/12/2007
- Grant date:
- 17/06/2015
- EP Publication Date:
- 17/06/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/01/2012
- EP B1 Publication Date:
- 17/06/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/12/2015
- Expiration date:
- 20/12/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/12/2007
- Name:
- Novarx
- Address:
- 6828 Nancy Ridge Drive, Suite 100, San Diego CA 92121-2635, United States (US)
Inventor
1
- Name:
- Fakhrai Habib
- Address:
- United States (US)
2
- Name:
- Shawler Daniel L.
- Address:
- United States (US)
Priority
- Priority Number:
- 876222 P
- Priority Date:
- 20/12/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 39/00;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|